
Asarfi Hospital Stock Hits New 52-Week High at Rs.221 Mark
2025-11-19 12:48:35Asarfi Hospital has reached a significant milestone by hitting a new 52-week high of Rs.221 today, marking a notable moment in the stock's recent performance and reflecting sustained momentum in the hospital sector.
Read More
Asarfi Hospital Stock Hits All-Time High, Marking a Significant Milestone
2025-11-19 12:32:08Asarfi Hospital has reached an all-time high, reflecting a remarkable phase in its market journey. The stock’s recent performance underscores its strong presence in the hospital sector, with notable gains and financial metrics that highlight its current standing.
Read More
Asarfi Hospital Stock Hits New 52-Week High at Rs.193.8
2025-11-18 12:10:52Asarfi Hospital has reached a significant milestone by hitting a new 52-week high of Rs.193.8, marking a notable achievement in its stock performance amid a mixed market environment.
Read More
Asarfi Hospital Stock Hits New 52-Week High at Rs.193.8
2025-11-18 12:10:52Asarfi Hospital has reached a significant milestone by hitting a new 52-week high of Rs.193.8 today, marking a notable moment in the stock’s recent performance and momentum within the hospital sector.
Read More
Asarfi Hospital Stock Hits New 52-Week High at Rs.193.8
2025-11-18 12:10:40Asarfi Hospital has reached a significant milestone by hitting a new 52-week high of Rs.193.8, marking a notable achievement in its stock performance. This peak reflects the stock's strong momentum over the past year, supported by robust financial metrics and consistent quarterly results.
Read More
Asarfi Hospital Stock Soars to All-Time High, Signaling Unmatched Market Strength
2025-11-18 09:46:44Asarfi Hospital has reached an all-time high stock price, reflecting its strong financial health and operational success. The company reported a significant net profit growth and record net sales for the recent quarter. Its low debt-to-EBITDA ratio further highlights its effective financial management and robust market position.
Read More
Asarfi Hospital Hits New 52-Week High of Rs. 186.5, Up 11.33%
2025-11-17 11:25:54Asarfi Hospital has achieved a new 52-week high, reflecting strong market performance and momentum. The stock has significantly outperformed its sector and delivered impressive annual returns. The company reported substantial net profit growth and record sales, alongside a favorable debt-to-EBITDA ratio, indicating solid financial health.
Read More
Asarfi Hospital Hits New 52-Week High of Rs. 186.5, Surges 11.33%
2025-11-17 11:25:51Asarfi Hospital achieved a new 52-week high of Rs. 186.5 on November 17, 2025, reflecting strong performance with an 11.33% gain over two days. The company reported a 34.38% increase in net profit and a low Debt to EBITDA ratio, showcasing robust financial health and significant returns over the past year.
Read More
Asarfi Hospital Hits New 52-Week High of Rs. 186.5, Surges 11.33%
2025-11-17 11:25:25Asarfi Hospital has achieved a new 52-week high, reflecting strong performance as it outpaces its sector. The stock has shown a robust upward trend, gaining over 11% in two days and trading above key moving averages. Its one-year performance significantly exceeds that of the broader market.
Read MoreAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
02-Dec-2025 | Source : BSEThis is to inform you that the Company will be meeting Investors/Analysts on dated November 04 2025 organized by Hem Securities - Samrudhi 2025 Virtual SME Conclave.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
27-Nov-2025 | Source : BSEWe wish to inform you that the management of the Company will be participating in Samruddhi2025(Season 2) - Nav Bharat ka Caravan Virtual Investor-Company Connect Conference organized by Hem Securities Limited which brings together some of Indias most emerging fast-growing and high-potential companies.
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
22-Nov-2025 | Source : BSEWe hereby submit the transcript of the Earning Conference call held on November 19 2025 wherein the Unaudited Standalone & Consolidated financial Results for the half year ended September 30 2025 (FY26).
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






